CANF analyst estimates

Can-Fite BioPharma (CANF) analyst ratings, the average price target and its range, and every firm's latest call.

CANF analyst ratings and price targets

DateFirmCallTarget
Jul 2, 2026H.C. WainwrightCan-Fite BioPharma (CANF) PT Raised to $8 at H.C. WainwrightMember Login$8.00
May 12, 2026H.C. WainwrightCan-Fite BioPharma target adjusted to $5 from $2.50 at H.C. Wainwright$5.00
Apr 15, 2025Industrial Alliance SecuritiesCan-Fite price target lowered to $4.50 from $12 at Alliance Global Partners$4.50
Jul 17, 2024EF HuttonCan-Fite BioPharma initiated with a Buy at EF Hutton$10.00